DLDCX
Price
$40.02
Change
-$0.45 (-1.11%)
Updated
Nov 13 closing price
Net Assets
975.77M
FIQRX
Price
$22.05
Change
-$0.10 (-0.45%)
Updated
Nov 13 closing price
Net Assets
920.12M
Interact to see
Advertisement

DLDCX vs FIQRX

Header iconDLDCX vs FIQRX Comparison
Open Charts DLDCX vs FIQRXBanner chart's image
BNY Mellon Natural Resources C
Price$40.02
Change-$0.45 (-1.11%)
VolumeN/A
Net Assets975.77M
Fidelity Advisor Global Commodity Stk Z
Price$22.05
Change-$0.10 (-0.45%)
VolumeN/A
Net Assets920.12M
DLDCX vs FIQRX Comparison Chart in %
View a ticker or compare two or three
VS
DLDCX vs. FIQRX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLDCX is a Buy and FIQRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DLDCX has more cash in the bank: 976M vs. FIQRX (920M). FIQRX pays higher dividends than DLDCX: FIQRX (2.30) vs DLDCX (0.50). DLDCX was incepted earlier than FIQRX: DLDCX (22 years) vs FIQRX (7 years). DLDCX (1.87) is less costly to investors than FIQRX (0.76). DLDCX is a more actively managed with annual turnover of: 103.94 vs. FIQRX (49.00). FIQRX has a lower initial minimum investment than DLDCX: FIQRX (0) vs DLDCX (1000). FIQRX annual gain was more profitable for investors over the last year : 18.43 vs. DLDCX (-5.24). FIQRX return over 5 years is better than : 109.81 vs. DLDCX (60.22).
DLDCXFIQRXDLDCX / FIQRX
Total Expense Ratio1.870.76246%
Annual Report Gross Expense Ratio1.870.76246%
Fund Existence22 years7 years-
Gain YTD8.49922.79337%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets976M920M106%
Annual Yield % from dividends0.502.3022%
Returns for 1 year-5.2418.43-28%
Returns for 3 years-23.9414.99-160%
Returns for 5 years60.22109.8155%
Returns for 10 years93.43N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLTE110.825.06
+4.78%
Belite Bio
NUE148.384.34
+3.01%
Nucor Corp
ABP6.030.05
+0.84%
Abpro Holdings Inc
SSYS9.540.02
+0.21%
Stratasys Ltd
HCAT2.46-0.23
-8.55%
Health Catalyst